Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
NCT: NCT07785102 · NOT_YET_RECRUITING
Brief Summary
In this pilot study, investigators aim to combine D-cycloserine, lurasidone, and single-day repeated intermittent Theta Burst Stimulation (iTBS) to preliminarily assess clinical improvement in an open-label cohort and monitor for adverse events over a 6-week follow-up period.
Frequently Asked Questions
What is Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101?
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 is a clinical trial registered under NCT07785102. Current status: NOT_YET_RECRUITING.
What is the status of NCT07785102?
The current status of NCT07785102 (Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101) is: NOT_YET_RECRUITING.
When did Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 start?
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.